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Effects of protein intake prior to
carbohydrate-restricted endurance exercise:
a randomized crossover trial
Mads S. Larsen1,2* , Lars Holm3, Mads V. Svart4,5, Astrid J. Hjelholt4, Mads B. Bengtsen4, Ole L. Dollerup4,
Line B. Dalgaard1, Mikkel H. Vendelbo6,7, Gerrit van Hall8,9, Niels Møller4,5, Ulla R. Mikkelsen2 and Mette Hansen1
Abstract
Background: Deliberately training with reduced carbohydrate availability, a paradigm coined training low, has
shown to promote adaptations associated with improved aerobic capacity. In this context researchers have
proposed that protein may be ingested prior to training as a means to enhance the protein balance during
exercise without spoiling the effect of the low carbohydrate availability. Accordingly, this is being practiced by
world class athletes. However, the effect of protein intake on muscle protein metabolism during training low has
not been studied.
This study aimed to examine if protein intake prior to exercise with reduced carbohydrate stores benefits muscle
protein metabolism in exercising and non-exercising muscles.
Methods: Nine well-trained subjects completed two trials in random order both of which included a high-intensity
interval ergometer bike ride (day 1), a morning (day 2) steady state ride (90 min at 65% VO2peak, 90ss), and a 4-h
recovery period. An experimental beverage was consumed before 90ss and contained either 0.5 g whey protein
hydrolysate [WPH]/ kg lean body mass or flavored water [PLA]. A stable isotope infusion (L-[ring-13C6]-
phenylalanine) combined with arterial-venous blood sampling, and plasma flow rate measurements were used to
determine forearm protein turnover. Myofibrillar protein synthesis was determined from stable isotope
incorporation into the vastus lateralis.
Results: Forearm protein net balance was not different from zero during 90ss exercise (nmol/100 ml/min, PLA:
0.5 ± 2.6; WPH: 1.8, ± 3.3) but negative during the 4 h recovery (nmol/100 ml/min, PLA: − 9.7 ± 4.6; WPH: − 8.7 ± 6.5);
no interaction (P = 0.5) or main effect of beverage (P = 0.11) was observed. Vastus lateralis myofibrillar protein
synthesis rates were increased during 90ss exercise (+ 0.02 ± 0.02%/h) and recovery (+ 0.02 ± 0.02%/h); no
interaction (P = 0.3) or main effect of beverage (P = 0.3) was observed.
Conclusion: We conclude that protein ingestion prior to endurance exercise in the energy- and carbohydrate-
restricted state does not increase myofibrillar protein synthesis or improve net protein balance in the exercising and
non-exercising muscles, respectively, during and in the hours after exercise compared to ingestion of a non-caloric
control.
Trial registration: clinicaltrials.gov, NCT01320449. Registered 10 May 2017 – Retrospectively registered,
https://clinicaltrials.gov/ct2/show/NCT03147001
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Introduction
During the past decade, ‘periodization’ has been a hot
topic in sports nutrition [1, 2]. The term ‘periodized nutri-
tion’ refers to strategic manipulation of nutrient availabil-
ity during training to promote specific adaptations.
Among the various strategies, undertaking training with
low carbohydrate availability has received much attention
by researchers [2–4]. This practice is popularly referred to
as training low. Several studies have shown that commen-
cing endurance-type exercise with low endogenous and
exogenous carbohydrate availability 1) augments the
mobilization of lipids for oxidation and 2) enhances
activation and gene transcription encoding key proteins
underpinning adaptations associated with a phenotype of
improved endurance capacity [5–10]. Among these pro-
teins, AMP-activated kinase (AMPK) and peroxisome
proliferator-activated receptor gamma coactivator (PGC)-
1α are reputed to play particularly important roles. AMPK
acts as a myocellular fuel gauge promoting fatty acid oxi-
dation, while PGC-1α is considered a master regulator of
mitochondrial biogenesis [3]. Congruently, training low is
employed by athletes to achieve greater aerobic and fat
oxidation capacity [11–13].
Nevertheless, training low comes with a caveat: Typic-
ally, amino acids contribute ~ 5% of the energy cost dur-
ing endurance exercise [14]. However, commencing
training with low carbohydrate availability may double
this contribution, seemingly brought about by accelerat-
ing muscle protein breakdown [15–17]. Indeed, low en-
dogenous carbohydrate availability augments leucine
oxidation [16] and amino acid release from the working
muscle [16, 17] and attenuates protein synthesis during
exercise [16]. Thus, repetitive practice over an extended
period has raised concerns among scientists [11, 18, 19],
as it may affect skeletal muscle mass negatively, and pos-
sibly compromise athletic performance. Accordingly, a
recent study estimated that commencing a 10-km run
with reduced carbohydrate availability increases daily
protein requirement by 0.12 g/kg.
As a means to ameliorate the augmented muscle pro-
tein breakdown, a few studies have examined the effect
of protein feeding before and during training low [20,
21]. These studies have shown that protein ingestion be-
fore training in a glycogen-depleted state does not seem
to compromise lipolysis and fat oxidation compared to
non-caloric placebo treatment [20, 21]. Furthermore,
Taylor et al. demonstrated that protein intake before
glycogen-depleted exercise did not influence acute
AMPK phosphorylation and PGC-1α mRNA transcrip-
tion. The authors also suggest that the protein provision
before and during the glycogen-depleted training bout
appeared to induce greater dephosphorylation (i.e. acti-
vation) of the eukaryote elongation factor 2 (eEF2) com-
pared to the placebo trial [20]. Because of its role as a
molecular regulator of elongation, the authors inferred
that protein ingestion during training low reduced sup-
pression of muscle protein synthesis during exercise
[20]. As acknowledged by the authors, a critical limita-
tion to their study is the lack of direct assessment of
muscle protein turnover.
Regardless of the limited scientific evidence, world-class
endurance athletes evidently already practice protein inges-
tion before and/or during training low sessions [12, 13].
Intrigued by the results by Taylor et al. [20] and the
reputed practice of world class athletes, we aimed to
conduct a proof-of-principle trial to determine how a
protein bolus ingested prior to commencing endurance
training in a carbohydrate/energy-restricted condition
affects skeletal muscle protein metabolism. We exam-
ined muscle protein synthesis in the highly active muscle
vastus lateralis and protein kinetics (i.e., net balance,
synthesis and breakdown) in the forearm to represent
non-exercising muscle tissue. The reason for this choice
was that whole-body protein kinetics may not reflect
that of the skeletal muscle tissue.
We hypothesized that protein ingestion prior to training
low would stimulate muscle protein synthesis in the exer-
cising muscles and would improve protein net balance in
non-exercising muscle. Additionally, we examined cell sig-
naling and gene expression associated with myofibrillar and
mitochondrial biogenesis to assess how these parameters
were affected by protein ingestion prior to training low.
Methods
Subjects
Twelve competitive male triathletes or cyclists were in-
cluded in the study after being deemed healthy and fit for
participation. The inclusion criteria required subjects to be
healthy (no metabolic abnormalities), non-smokers, 18–50
years old with a relative V̇O2peak above 55ml O2/kg/min,
and a history of five or more training sessions per week for
6 months prior to inclusion. All participants were given oral
and written information and gave their written consent to
participate. The study was approved by the local ethical
committee of the Central Denmark Region (M-20110035)
and was conducted in accordance with the Declaration of
Helsinki. The study was registered with clinicaltrials.gov
(NCT01320449).
Pretesting
Prior to the experiment, a routine blood sample was col-
lected to determine the subject’s general metabolic health.
The blood samples were collected in the fasted state and
analyzed for levels of low density lipoprotein, high density
lipoprotein, triglycerides, leucocytes, aminotransferase, as-
partate aminotransferase, alkaline phosphatase, albumin,
testosterone, thyroid stimulating hormones, triiodothyron-
ine, creatine kinase, c-reactive protein and hemoglobin to
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get an indication of any undiagnosed conditions that the
participant might unknowingly have suffered from.
Body composition was determined using dual-energy
x-ray absorptiometry (DXA; GE Lunar DXA scan, GE
Healthcare, USA).
Peak power output (PPO) and peak oxygen consump-
tion (V̇O2peak) were determined independently of the ex-
perimental trials and DXA scan, using an incremental
test-to-exhaustion on an electronically braked bicycle
ergometer (SRM, Julich, Germany) as described previ-
ously [22]. V̇O2peak was defined as the highest oxygen
uptake attained during any 30 s of the test. Respiration
was analyzed using an Oxigraf O2CPX (Oxigraf O2CPX,
Model Part Number 07–0464, Oxigraf Inc) with Innocor
8.00 software (Innovision ApS, Odense, Denmark). PPO
was calculated from the highest completed stage of exer-
cise intensity plus the fraction of time spent in the final
uncompleted stage [22]. The individual PPO was used to
determine the prescribed intensities during the experi-
mental trials.
Study design
The protocol is visualized in Fig. 1. In a single-blinded
counterbalanced crossover trial, subjects were studied
on two occasions (Visit 1 and Visit 2) separated by a
minimum of 14 days. The contents of the experimental
beverage (whey protein hydrolysate [WPH] or placebo
[PLA]) differed; otherwise, the experiments were con-
ducted in a similar manner. Each experimental period
covered 2 days and consisted of two exercise sessions
performed on an ergometer bike, similar to the protocol
described by Lane et al. [7]: the first high-intensity inter-
val training (HIIT) session was performed in the evening
of Day 1. The second session, a 90 min steady state
(90ss) cycling bout, was performed at 08.00 h on the fol-
lowing morning (Day 2). All foods consumed on Day 1
were standardized and matched between the two visits.
Experimental beverages were ingested immediately prior
to 90ss. Ingestion of food and beverages other than
water and the experimental beverage was not allowed
from arrival at the laboratory until completion of Day 2.
Throughout Day 2, fractional protein synthesis rates
(FSR) and muscle protein turnover were determined
using stable isotope tracer techniques.
Experimental days
At both visits, the subjects reported to the laboratory at
1800 h on Day 1. After voiding their bladder, they com-
menced the HIIT session. Afterwards a catheter was
placed in an antecubital vein. A background blood sam-
ple was collected and the catheter was kept patent by
continuous infusion of 9% saline until 0330 h (0530 h at
the second visit), when a primed (6.0 μmol/kg lean body
mass [LBM]) continuous (6.0 μmol/kg LBM/h) infusion
of L-[ring-13C6]-phenylalanine (Cambridge Isotopes, An-
dover, MA, USA) was initiated and maintained until the
end of Day 2 (1330 h). Tracer solutions were sterilely
prepared and tested free of bacteria and pyrogens before
use. In the morning of Day 2, a catheter was placed con-
tralaterally to the tracer infusion in an antecubital vein,
in a retrograde direction, for deep venous sampling.
Another catheter was placed in a dorsal hand vein. The
hand was heated to ~ 55 °C for sampling of arterialized
blood. Venous occlusion plethysmography was used to
determine forearm blood flow.
Immediately before commencing 90ss, a baseline
muscle biopsy and blood samples were obtained, and the
experimental beverage was consumed. After completion
of 90ss, the subjects were kept in a supine position for
the rest of the experiment. A muscle biopsy was ob-
tained immediately, and at 1 and 4 h of after termination
of the 90ss. Urine was collected in two intervals. Batch
1: From the initiation of HIIT to the commencement of
90ss. Batch 2: From the commencement of 90ss to the
end of the study period.
HIIT
After a self-chosen 10-min warm up, the HIIT session
was performed on an ergometer bike (LC4, Monark AB,
Vangsbro Sweden). The HIIT consisted of ten 5-min
bouts at ~ 82.5% of individual PPO with 90 s of active re-
covery between the intervals. This protocol is a modified
version of one described by Stepto et al., which showed
a ~ 50% reduction in muscle glycogen levels [7, 23].
Fig. 1 Overview of study design. On day 1, all meals were provided. At 1900 subjects commenced 10 × 5min intervals at 82.5% (HIIT) of
individual peak power output (PPO) on a customized ergometer bike. L-[ring-13C6-phenylalanine] was initiated during the night. Upon awakening
(day 2), blood, muscle and urine samples were collected before commencement of a 90 min steady state ride (55% PPO). Subsequently subjects
rested in a supine position for 4 h. Samples were collected as indicated
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90ss
The work rate was fixed at 55% of PPO. The bicycle erg-
ometer was modified by addition of customized aerobars
with an attached table for hand placement (subjects did
not grip the handle bars). The subjects were instructed
to remain positioned in the aerobars throughout the ex-
ercise bout to minimize muscle activity in the forearms
while cycling. VO2 was measured during 5-min intervals
every 30 min of exercise. Ratings of perceived exertion
were recorded prior to VO2 measurements. Heart rate
was measured continuously throughout 90ss. The work
performed during the HIIT and 90ss sessions at Visit 1
was replicated at Visit 2.
Diet and exercise control
On Day 1, a standardized portion-controlled diet contain-
ing (per kg body weight) 6.8 g carbohydrate, 1.8 g protein,
and 1.7 g fat was provided for all participants. No exercise,
alcohol, caffeinated drinks, or medical drugs were allowed
in the 24 h prior to HIIT. Water was allowed ad libitum at
all times during the experimental periods.
Experimental beverages
were provided immediately before starting the 90ss ses-
sion and contained either 0.5 g/kg LBM WPH (Lacpro-
dan® HYDRO.365, Arla Foods Ingredients Group P/S,
Viby J, DK) with 10% L-[ring-13C6]-phenylalanine en-
richment (Table 1) or a non-caloric placebo matched for
flavor. The amino acid content of the protein beverage is
appended (see Additional file 1).
Blood sampling and analysis
All blood samples were collected into coated vacuum
blood collection tubes. Plasma amino acid concentra-
tions and enrichments were determined as described
previously [24]. Concentrations of insulin, cortisol,
serum glucose, and plasma-free fatty acids (FFA) were
quantified as described previously [25, 26]. Hemoglobin
(HemoCue Hb 201+, Ängelholm, Sweden) and 3-
hydroxybuterate (FreeStyle Precision; Abbott Diabetes
Care) were measured immediately after sampling. Ana-
lyses of plasma and urinary urea and plasma ammonium
were performed using absorption photometry (Cobas
6000, Roche, Basel, CH and Chemistry XPT System,
Simens Healthcare A/S, Ballerup, DK).
Muscle biopsies sampling and analyses
The muscle biopsies (~ 250 mg) were obtained from the
vastus lateralis muscle under local anesthesia (10 ml
Xylocain® 10 mg/ml, AstraZeneca, Sweden) using a 5
mm Bergström needle with manual suction. At each
visit, all samples were obtained from the same randomly
chosen leg (dominant or non-dominant) through separ-
ate incisions. After removing visible blood, fat, and con-
nective tissue, the samples were snap frozen and stored
at − 80 °C until further analysis.
Stable isotope analysis
For practical reasons, a single biopsy approach was used to
assess basal muscle protein FSR at Visit 1 [24, 27, 28]. This
value represents basal FSR for both treatments in the statis-
tical analysis. Myofibrillar and mitochondrial proteins were
isolated as described previously [29]. Briefly, each muscle
sample (~ 25mg wet weight) was homogenized in 1ml
homogenization buffer (0.02M Tris [pH 7.4], 0.15M NaCl,
2mM EDTA, 0.5%, TritonX-100 and 0.25M sucrose) and
spun at 800 g at 5 °C. This procedure was repeated. The
resulting supernatants were combined and spun at 10,000 g
(5 °C), washed, and spun in 1ml 70% ethanol (1600 g, 5 °C)
to pellet the mitochondrial proteins. The original pellet con-
taining myofibrillar and connective tissue proteins was vor-
texed, left overnight (5 °C) in a KCl buffer (0.7M KCl, 0.1M
pyrophosphate) and then spun at 1600 g (20min, 5 °C). The
supernatant was discarded and 99% ethanol was added and
left for 2 h. This procedure was repeated. The resulting myo-
fibrillar protein pellet was hydrolyzed at 110 °C in 6M HCl
overnight. Both the mitochondrial and myofibrillar amino
acids were purified over prepared resin columns (AG 50W-
X8 resin; Bio-Rad Laboratories, Hercules, CA), eluted with 4
M NH4OH, and evaporated under a stream of nitrogen be-
fore being derivatized as the N-acetyl-propyl derivative as de-
scribed elsewhere [30]. Unfortunately, several samples from
the mitochondrial fraction resulted in signals too low to de-
tect on the GC/C/IRMS. Therefore, we were unable deter-
mine the FSRs for mitochondrial protein.
Calculations
Calculations of forearm phenylalanine kinetics and
muscle protein FSRs were performed as described by
Smith et al. [31] and Holm et al. [24], respectively. Cal-
culations are appended (see Additional file 2).
Gene expression
Approximately 20 mg of muscle tissue was homogenized
using a Precellys 24 Tissue Homogenizer (Bertin Instru-
ments, Rockville, MD, USA). Total RNA was isolated
using an RNA KIT (Qiagen, #217004) according to the
manufacturer’s instructions. Concentrations and purity
were confirmed by spectroscopy. All reagents and equip-
ment used were from Applied Biosystems™ (Foster City,
Table 1 Protein beverage content / 100 g
Water 85.52 g




All subjects ingested a drink with a protein content equivalent to 0.5 g/kg LBM
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Ca, USA). Five hundred nanograms of RNA was con-
verted to cDNA using a High-Capacity cDNA Reverse
Transcription Kit, and real time PCR was performed
with Fast Advanced Mastermix using a StepOnePlus.
Genes (targets IDs) were: CPT1B (HS03046298 s1),
COX4I1 (HS00971639 m1), PPARGC1 (HS00173304
m1), TFAM (HS01082775 m1), RPLP0 (HS99999902
m1) and GAPDH (HS99999905 m1). Data were con-
verted to fold changes from PRE using the Delta Delta
Ct method [32] with RPLP0 as the internal control. Ct
values obtained for RPLP0 were not affected by treat-
ment or time.
Western blots
Approximately 30mg of muscle tissue was used to deter-
mine protein concentrations via Bradford assays (Bio-Rad,
Ca, USA). Target proteins were resolved by 4–15% sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (Criter-
ion TGX gradient 4–15%, Bio-Rad) with three molecular
markers (Precision Plus All Blue, Bio-Rad) and an internal
control before being electroblotted to polyvinylidene
difluoride membranes (Bio-Rad, CA, USA). The mem-
branes were blocked in I-block™ Protein-based Blocking Re-
agent (Applied Biosystems™, Bedford, MA, USA) and
incubated overnight in primary antibodies followed by
TBS-T wash and incubation (1 h) with secondary anti-
bodies. Primary antibodies (cat. no.): p-mTORser2448
(2971), p-p38MAPKthr180/tyr182 (4511), p-p70S6Kthr389
(9205), p-eIF4Eser209 (9741) and p-p53ser15 (9284), all
from Cell Signaling Technology (Danvers, MA, USA).
Horseradish peroxidase-conjugated secondary anti-
bodies: Goat anti-rabbit IgG H&L (ab6721; Abcam,
Cambridge, UK) and Anti-mouse IgG (7076; Cell Signal-
ing Technology (Danvers, MA, USA).
Proteins were visualized using a chemiluminescence
detection system (Thermo Scientific, IL, US) and quanti-
fied using a Bio spectrum 500 Imaging System (UVP,
Cambridge, UK). All Blue Standards (Bio-Rad, CA, USA)
were used as molecular weight markers.
Statistical analysis
An a priori sample size of ten subjects was established
based on previous tracer kinetics data from trials similar
to ours [33, 34]. For each treatment (PLA or WPH),
time-weighted arithmetic means were calculated for each
time period (BL, 90ss and BR) to determine a conjoined
and clinically meaningful response for plasma metabo-
lites, hormones and tracer kinetic data. Data on muscle
signaling were analyzed and expressed as relative fold
change from baseline corresponding to the biopsy
obtained immediately before commencing 90ss at each
visit. For gene expression, delta CT values were analyzed
statistically but expressed as relative fold changes from
baseline. Statistical analyses were conducted using a
repeated-measures mixed effects model. Treatment, time
period (BL, 90ss and BR), and order-of-treatment were
included as independent variables. Subject and visit (1 or
2) were included in the random part of the model to ac-
count for any carry-over effect and random intercepts
for the subjects, respectively. This was followed by a
joint test of two-way interactions. Significance was set at
an α-level of < 0.05. If F-ratios were significant, Bonfer-
roni post hoc tests were applied to locate differences.
Normality and heteroskedasticity of all data were
checked by visually inspecting QQ-plots and plots of re-
siduals versus the fitted values. No obvious deviations of
normality were detected. Data that were not homosce-
dastic (3-hydroxybutyrate, plasma ammonia and amino
acid concentrations) were log-transformed for the statis-
tical analyses but not presented as such. Treatment dif-
ferences in urinary nitrogen excretion and volume of
voiding were analyzed using paired t-tests. Values are
presented as means ± standard deviation (SD). All statis-
tical analyses were performed using STATA version 14.2
(StataCorp LP, Collage Station, TX, USA).
Results
Study participants
Of the 12 subjects included in the study, two failed to at-
tend the experimental visits; one due to injury unrelated
to the study and one due to scheduling difficulties. One
subject did not attend the second trial for personal
reasons and was therefore excluded from all analyses.
Subject characteristics are shown in Table 2.
HIIT and 90ss
The mean PPO attained during pretesting was 364 ±
24 watts. The average power output across intervals
was 281 ± 21 watts. On average, participants dropped
~ 4.6% between interval one and ten (95% CI: − 6.7,
− 2.4; P < 0.001). Concomitantly, the rating of per-
ceived exertion rose from ~ 14 to ~ 18 on the Borg
scale (P < 0.001). The 90ss sessions were performed at
an average power of 55.6 ± 2.6% (PLA) and 54.9 ±
2.9% (WPH) of PPO. During both trials, the mean
respiratory exchange ratio dropped from 0.87 to 0.84
throughout the 90ss session (P < 0.001).
Table 2 Subject characteristics (n = 9)
Age (years) 28.6 ± 9.0
Body mass (kg) 73.1 ± 4.5
DXA body mass (kg) 73.7 ± 4.3
Lean body mass (kg) 60.1 ± 4.2
VO2peak (ml O2 • kg
− 1 • min− 1) 60.0 ± 2.6
Peak power output (watt) 364 ± 24
Data are mean ± SD
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Blood profile
All blood profiles are illustrated in Fig. 2. Serum insulin
(Fig. 2a) was 12.5 pmol/L higher in WPH than in PLA dur-
ing 90ss (P = 0.02; 95% CI: 0.9, 24.1), as insulin levels in
PLA dropped 12.3 pmol/L from BL levels (P = 0.03; 95% CI:
− 23.9, − 0.7). Both treatments showed lower insulin levels
during BR than at BL (P < 0.05; 95% CI: − 10.1, 13.1).
Plasma cortisol increased during 90ss for both treatments
and returned to BL levels during BR. No time-treatment
interaction was observed (P = 0.34); yet, statistical analysis
showed higher plasma cortisol throughout PLA compared
with WPH (+ 36.1 μg/L; P < 0.01; 95% CI: 62.4, 9.8; Fig. 2b).
Blood glucose was reduced throughout Day 2 in both
WPH and PLA (Fig. 2c; P < 0.001). Though not statistically
significant, there tended to be an interaction with WPH
showing higher glucose levels than PLA (P = 0.097). FFA
concentrations in PLA were increased during 90ss (0.92 ±
0.22mmol/L; P = 0.03; 95% CI: 0.02, 0.58; Fig. 2d) com-
pared with BL (0.62 ± 0.20mmol/L) and further during BR
(1.44 ± 0.10mmol/L; P < 0.001). In WPH, the FFA levels
were unchanged from BL during 90ss (mmol/L: 0.59 ± 0.21
vs 0.73 ± 0.29; P = 1.0; 95% CI: − 0.14, 0.43), but rose during
BR (1.04 ± 0.30mmol/L; P < 0.001; 95% CI: − 0.17, 0.73).
Plasma 3-hydroxybutyrate concentrations were unchanged
Fig. 2 Blood parameters. Change in hormone and metabolite levels during BL, 90ss and BR. Insulin (a), cortisol (b), glucose (c), free fatty acids
(FFA) (d), 3-hydroxybutyrate (e), urea (f). Data are shown as means ± SD (n = 9); P < 0.05. Means within each trial with different subscripts are
significantly different from each other; WPH subscripts are in cursive. # Significant difference between PLA and WPH at each respective timepoint
Larsen et al. Journal of the International Society of Sports Nutrition            (2020) 17:7 Page 6 of 13
during 90ss for both treatments (Fig. 2e; P > 0.05) but were
increased for both treatments during BR (P < 0.001). There
tended to be a period x treatment interaction (P = 0.082).
Plasma urea rose throughout the experimental day in both
treatments (Fig. 2f; P < 0.001) but was higher for WPH (+
1.0mmol/L; 95% CI: 0.5, 1.6; P < 0.001) than for PLA dur-
ing 90ss and BR (+ 1.6mmol/L; P < 0.001; 95% CI: 1.1, 2.2).
Plasma ammonium concentrations were increased
during 90ss (μmol/L: PLA, 85.8 ± 21.6; WPH, 87.7 ±
22.3) for both treatments (P < 0.001) and returned to
BL (μmol/L: PLA, 44.7 ± 9.6; WPH, 44.8 ± 9.5) during
BR (μmol/L: PLA, 38.8 ± 7.3; WPH, 38.6 ± 4.8). Arter-
ial phenylalanine concentration increased during 90ss
in both treatments, but more so in WPH than in
PLA (Fig. 3a; P < 0.001). Arterial leucine concentra-
tions increased after protein consumption only and
stayed elevated into BR (Fig. 3b; P < 0.001). Arterial
phenylalanine enrichment had reached a plateau be-
fore commencing 90ss. A slight increase was observed
immediately after 90ss in WPH (Fig. 4; P < 0.001).
Urinary urea nitrogen excretion was higher (+ 147
mg/hr.; P = 0.03; 95% CI: 13, 281) in WPH (613 ± 165
mg/hr) than in PLA (466 ± 93 mg/hr) during the ex-
perimental day (Day 2). Urine production was similar
in both treatments (mL/h: PLA, 48 ± 12; WPH, 51 ± 12;
P = 0.65).
Forearm protein kinetics
Forearm phenylalanine net balance was negative at
baseline (Fig. 5a). During 90ss, a tendency towards
increased rates of amino acid uptake by the forearm
(Fig. 5b) was observed. This resulted in a neutral net
protein balance in both groups. During BR, the rates of
amino acid released from the arm increased (Fig. 5c;
P = 0.01), yielding a negative net protein balance.
During 90ss forearm plasma flow decreased compared to
BL (Fig. 6; P < 0.001) and increased to a level above BL
during BR (Fig. 6; P < 0.001).
Fractional synthetic rate
Vastus lateralis FSR was increased during 90ss and BR
for both treatments (Fig. 7; P < 0.05).
Muscle signalling and gene expression
Western blotting
In WPH, mTOR phosphorylation was increased imme-
diately after 90ss compared with BL (Fig. 8a; + 58%;
95% CI: 6, 111; P = 0.01) and PLA (+ 64%; 95% CI: 6,
121; P = 0.017). Also, an overall treatment effect was
observed for p70S6K (Fig. 8b; + 20% in WPH; 95% CI:
9, 31; P < 0.001). p53 phosphorylation tended (P = 0.08)
to be decreased immediately (Fig. 8c; − 20; 95% CI: − 38,
− 2) and 60min (− 22%; 95% CI: − 40, − 4) after 90ss
across treatments. p-eIF4E and p-p38MAPK were not
affected by time or treatment (Fig. 8d & e; P > 0.05).
Fig. 3 Arterial concentrations of phenylalanine (a) and leucine (b) at baseline (BL), during 90 steady state exercise (90ss) and during bed rest
recovery (BR) with PLA or WPH ingestion. Values are means ± SD (n = 9); P < 0.05. Means within each trial with different subscripts are significantly
different from each other; WPH subscripts are in cursive. # Significant difference between PLA and WPH at each respective timepoint
Fig. 4 Arterial phenylalanine enrichment at baseline (BL), during 90
steady state exercise (90ss) and bed rest recovery (BR) with PLA or
WPH ingestion. Values are means ± SD (n = 9); P < 0.05. Means
within each trial with different subscripts are significantly different
from each other; WPH subscripts are in cursive. # Significant
difference between PLA and WPH at each respective timepoint
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Real-time PCR
In response to 90ss, PGC1α mRNA expression increased
throughout the day to about fivefold at the end of Day 2
(Fig. 9a; P < 0.001). An overall time effect was observed
for TFAM mRNA, but post hoc tests revealed no differ-
ences from baseline for either treatment (Fig. 9b).
CPT1B was suppressed immediately after 90ss compared
with prior to 90ss (Fig. 9c; P < 0.001) and there tended
to be an overall treatment effect indicating a higher
expression of CPT1B in the PLA than WPH trial
(P = 0.09). COX4I1 was not affected by time or treat-
ment (Fig. 9d; P > 0.05).
Discussion
The main finding of the present study was that supple-
mentation with ~ 35 g of protein (0.5 g / kg LBM) did
not enhance protein net balance in the forearm or in-
crease vastus lateralis myofibrillar protein synthesis com-
pared to the placebo treatment, despite inducing a rapid
increase in plasma amino acid concentrations that lasted
into post-exercise recovery. To our knowledge, this is
the first study to examine the direct impact of protein
ingestion on muscle protein turnover (forearm) and syn-
thesis rates, while training in a state of reduced carbohy-
drate availability. We used stable isotope tracers to
determine protein turnover in the non-exercising
muscles (forearm) and fractional protein synthesis in the
exercising vastus lateralis muscles during and after
bicycle exercise.
Other investigators have hypothesized that protein
feeding would mitigate the reputed increase in muscle
protein breakdown during exercise by providing sub-
strate for gluconeogenesis and oxidation. A further
suggested benefit was that the ingested protein would
enhance the muscle protein synthesis rate when train-
ing with low exogenous and endogenous carbohydrate
availability (training low) [20, 35]. Furthermore, pre-
vious reports suggest that the enhanced adaptive re-
sponse induced by training low is not hampered by a
preceding and/or concomitant protein intake [20, 21].
Indeed, protein ingestion during and/or after endur-
ance type exercise has been shown to enhance muscle
protein synthesis [33, 34, 36, 37]. However, our data
endorse the notion that endurance exercise blunts the
anabolic response to hyperaminoacidemia [33, 37],
possibly as a part of a metabolic priority shift towards
Fig. 5 Forearm plasma flow at baseline (BL), during 90 steady state
exercise (90ss) and bed rest recovery (BR) with PLA or WPH
ingestion. Values are means ± SD (n = 9); P < 0.05. Means within
each trial with different subscripts are significantly different from
each other; WPH subscripts are in cursive
Fig. 6 Forearm net protein balance (a), forearm protein synthesis (b), forearm protein breakdown (c) at baseline (BL), during 90 steady state
exercise (90ss) and during bed rest recovery (BR) with PLA or WPH ingestion. Values are means ± SD (n = 9); P < 0.05. Means with different
subscripts are significantly different from each other
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energy transduction and conservation as proposed by
Atherton and Rennie [38].
Amino acid kinetics and muscle protein synthesis
We observed that vastus lateralis muscle protein syn-
thesis rates were elevated during and after exercise in
both the PLA and the WPH trial. Thus, our data con-
firm the findings of Beelen et al., who also showed an
increase in muscle FSR in response to endurance type
exercise with and without exogenous protein provision
[37]. Based on observed increases in muscle free amino
acid concentrations, Beelen and colleagues suggested
that the muscle FSR increase may be attributed to an
increased provision of endogenously derived amino
acids to the working muscle facilitated by increased
blood flow. While this seems a plausible explanation,
our tracer kinetics data from the forearm does not sug-
gest that less active muscle tissue becomes a supplier of
such amino acids given our results show an increased
net protein balance from BL to 90ss in both the WPH
and PLA trials. Other studies examining combined pro-
tein and carbohydrate ingestion during moderately in-
tense endurance exercise have shown enhanced whole-
body [34, 37, 39] and leg [33] protein synthesis and net
protein balance compared with carbohydrate or non-
fed controls. While the inconsistency between these
findings and ours may be influenced by the tissue ex-
amined, the lack of carbohydrate and/or energy avail-
ability in our subjects likely attenuated the anabolic
response to hyperaminoacidemia. Furthermore, we can-
not dismiss that the provision of exogenous amino
acids via the WPH drink may have ameliorated the
muscle protein breakdown in the legs, as observed by
Hulston et al. (2011) albeit in subjects who were not
reduced in muscle glycogen.
Although we did not measure muscle glycogen content
directly, we believe that the HIIT session had lowered
the muscle glycogen content significantly. Indeed, simi-
lar depletion protocols have been shown to reduce
muscle glycogen ~ 50% [7, 23]. Furthermore, these stud-
ies show that the achieved reductions in muscle glyco-
gen persisted until the following morning [7, 17, 40].
Blood parameters
In accordance with our tracer kinetics data, showing no
effect of protein ingestion, plasma metabolite concentra-
tions indicate that the ingested protein bolus was metab-
olized rather than used as substrate for protein synthesis
in the muscle tissues. Had we had access to intrinsically
labelled protein, we could have traced the fate of the
ingested amino acids. However, the observations of ele-
vated plasma urea in WPH vs PLA (90ss: + 17%; BR: +
24%), accompanied by a borderline time x treatment
interaction for plasma glucose levels, imply that amino
acids were used as an energy substrate. Moreover, the
WPH treatment yielded an overall lower level of cortisol,
suggesting that the more stable blood glucose and larger
energy substrate provision rendered the subjects less
stressed and possibly less catabolic.
The WPH produced an increase in serum insulin con-
centration compared with the PLA trial. Even though
the plasma insulin levels did not rise above rest levels,
the slightly higher insulin levels observed in WPH dur-
ing 90ss may have borne clinical relevance in suppress-
ing lipolysis [41]. Previous studies have shown that
insulin repression during exercise is crucial for FFA
mobilization and that failure to suppress insulin during
exercise blunts plasma FFA markedly [42, 43]. Accord-
ingly, we observed depressed levels of FFA following ex-
ercise in WPH compared to PLA.
Myocellular signaling and mRNA-transcription
Despite WPH being ineffective in augmenting protein
synthesis above the PLA trial, WPH elevated phos-
phorylation in some of the signaling targets involved in
translational control of protein synthesis. p-mTOR and
p-p70S6K (but not p-eIF4E) showed an elevated relative
abundance both immediately and 60 min after comple-
tion of 90ss. This confirms the trend shown by Taylor
et al., suggesting an enhanced activity of key regulators
of protein synthesis during carbohydrate-restricted exer-
cise if a protein feeding stimulus is provided [20]. Still,
from our tracer kinetics data it appears that the energy
costly process of translation may be relegated. Thus,
WPH seems to have induced a more anabolic environ-
ment; but the stimulus was not translated into a
detectable alteration of the protein synthesis rate. Fur-
thermore, signaling kinases reputed to be key regulators
of mitochondrial biogenesis, i.e. p53 and p38MAPK,
Fig. 7 Muscle protein FSR of the m. vastus lateralis during baseline
(BL), 90 min steady state exercise (90ss) and bed rest recovery (BR)
with PLA or WPH ingestion. BL FSR’s were performed at Visit 1
regardless of treatment (hatched bars). Values are means ± SD (n =
9); P < 0.05. * Significantly different from BL
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were unaffected by treatment. The observed develop-
ment for p-p53 and p-p38MAPK must be interpreted on
the basis of the previous evening’s HIIT session and
subsequent overnight fast. Presumably, the phosphoryl-
ation of these targets was likely already augmented at
the time the baseline biopsy. Thus, comparing these
Fig. 8 Protein phosphorylation. Mammalian target of rapamycin (mTOR) (a), ribosomal protein S6 kinase beta-1 (p70S6K) (b), eukaryotic
translation initiation factor 4E (EIF4E) (c), tumor protein p53 (p53) (d), p38 mitogen-activated protein kinases (p38MAPK) (e). Western blots
representing the time-course effects are presented below the graphs. Based on the applied molecular standards, approximated molecular
weights are indicated to the right. n = 9 for all timepoints. Values are normalized to PRE 90ss and are expressed as means ± SD; P < 0.05. *
Significantly different from BL. # Significant difference between trials
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results to the growing body of literature showing in-
creases in p53 and p38MAPK phosphorylation as an ef-
fect of a single bout of exercise commenced with
reduced muscle glycogen availability (for review see
Hawley and Morton [3]) would be inappropriate and, in-
deed, falls beyond the scope of the present study. While
the phosphorylation of p53 and p38MAPK was more or
less unaffected by exercise, PGC-1α mRNA expression
was elevated in both trials. This suggests that signaling
cascades preceding transcription of genes encoding pro-
teins involved in mitochondrial biogenesis were activated
in response to exercise, and that this positive adaptive
response did not appear to be negatively affected by
protein feeding prior to exercise.
Limitations
To isolate the effect of the protein ingestion prior to
carbohydrate restricted training, we chose a proof-of-
principle approach. We acknowledge that the omission
of post-exercise food intake does not directly translate to
a real-world setting. Yet, this approach allowed us gain
an understanding of the influence of this particular feed-
ing strategy both during and after training. Furthermore,
the addition of post-exercise feeding would have posed
even greater methodological challenges in regard to the
stable isotope tracer techniques. As we measured the
fractional synthesis rate only, we were unable to assess
the direct effect of WPH on muscle protein breakdown
in the working muscle and evaluate the impact on
muscle protein net balance, which may have been
affected by protein ingestion per se and by the higher
level of insulin in WPH compared to PLA.
Measuring protein turnover during feeding and exer-
cise prompts some methodological challenges arising
from physiological perturbations. We used plasma tracer
enrichments as a surrogate precursor estimate. Under
resting conditions, circulating tracer enrichments, are
higher than the intramuscular enrichments [24] and the
transfer-RNA precursor enrichment [44, 45]. This results
in an underestimated FSR. During and immediately after
exercise, however, the intramuscular tracer enrichment
is approaching the level in the circulation [46], resulting
in a slighter overestimation of the real precursor enrich-
ment, hence a reduced underestimation of the FSR. We
argue that with the use of precursor estimates in the
present study, the FSR at basal and in recovery condition
Fig. 9 Gene expression. mRNA expression of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) (a), mRNA
expression of mitochondrial transcription factor A (TFAM) (b), mRNA expression of cytochrome c oxidase subunit IV (COXIV) (c), mRNA expression
of carnitine palmitoyl transferase 1B (CPT1B) (d). n = 9 for all timepoints. Values are set relative to PRE 90ss and the fold changes are expressed as
means ± SD; P < 0.05. Means within each trial with different subscripts are significantly different from each other. # Significant difference
between trials
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is more underestimated than during exercise. If any-
thing, the difference in FSR during exercise (90ss) com-
pared to the basal and recovery condition is smaller than
what we report. Conservatively, we suggest that our
quantitative measures should be interpreted as indica-
tive. Still, we find that our collective portfolio of out-
comes supports our tracer kinetics data and forms a
basis from which a valid conclusion may be drawn. Fur-
thermore, our sample size was small which may have re-
duced our ability to detect statistical effects for muscle
protein turnover. Additionally, it is worth noting, that
the participants in the present trial were all men. This
potentially limits broader inferences of our findings, i.e.
to the female athletic population. Finally, our partici-
pants were trained, but not all part of the international
elite of endurance athletes. We cannot rule out that
training status influence protein turnover at the response
to protein supplements.
Summary
In summary, we provide novel data showing that protein
ingested prior to endurance-type exercise in the energy-
and carbohydrate-restricted state does not enhance myo-
fibrillar FSR in the working muscles or improve muscle
protein balance in the non-working muscles compared
to ingestion of non-caloric control. Presumably, this ob-
servation is linked to a metabolic priority shift towards
energy preservation. During exercise, we observed slight
augmentations in muscle protein synthesis rates in the
exercising muscles and net balance in the non-exercising
muscles, independently of protein feeding. This suggests
that the practice of commencing training in a glycogen-
depleted/fasted condition to enhance endurance-training
adaptations does not appear to pose any significant risk
in regard to losing skeletal muscle mass. However, pro-
tein breakdown is upregulated following exercise, at least
in non-exercising muscles, thus sufficient refueling in
terms of protein and carbohydrate is crucial to induce
an anabolic hormone response, stimulate glycogen re-
synthesis and protein synthesis, as well as attenuate
protein breakdown.
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